Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2012
10/18/2012US20120264792 Furazanobenzimidazoles as prodrugs to treat neoplastic or autoimmune diseases
10/18/2012US20120264791 Fatty acid niacin conjugates and their uses
10/18/2012US20120264790 Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals
10/18/2012US20120264789 Polymorphs of sorafenib acid addition salts
10/18/2012US20120264788 Animal parasite-control method using insect growth regulators
10/18/2012US20120264787 Respiratory Disease Treatment
10/18/2012US20120264786 Use of thiazolidinediones for the partial inhibition of androgen binding to aromatase
10/18/2012US20120264785 Fluoro-substituted 3,5-dicyano-4-(1H-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereof
10/18/2012US20120264784 Methods of treating elevations in mtor signaling
10/18/2012US20120264783 Methods for the treatment of cns-related conditions
10/18/2012US20120264782 Compositions for the treatment of cns-related conditions
10/18/2012US20120264781 Method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition
10/18/2012US20120264780 Solid compositions
10/18/2012US20120264779 Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
10/18/2012US20120264778 Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy
10/18/2012US20120264777 Oxadiazole beta carboline derivatives as antidiabetic compounds
10/18/2012US20120264776 Menthol liquids composition
10/18/2012US20120264775 Oligomer-Opioid Agonist Conjugates
10/18/2012US20120264774 Forms of rifaximin and uses thereof
10/18/2012US20120264773 Organic compounds
10/18/2012US20120264772 Antihypertensive pharmaceutical composition
10/18/2012US20120264771 Method for Treating Androgen Receptor Positive Cancers
10/18/2012US20120264770 Hsp90 inhibitors
10/18/2012US20120264769 Methanocarba adenosine derivatives and dendrimer conjugates thereof
10/18/2012US20120264768 Bicyclic and tricyclic pyrimidine tyrosine kinase inhibitors with antitubulin activity and methods of treating a patient
10/18/2012US20120264767 Stable pharmaceutical composition of freeze-dried tetrodotoxin powder
10/18/2012US20120264766 Pseudobase benzo[c]phenantridines with improved efficacy, stability and safety
10/18/2012US20120264765 Cyclohexane-1,3-Diones for Use in the Treatment of Amyotrophic Lateral Sclerosis
10/18/2012US20120264764 Oxabicycloheptanes and Oxabicycloheptenes, Their Preparation and Use
10/18/2012US20120264763 Indoline Anti-Cancer Agents
10/18/2012US20120264762 Heterocyclic Compounds as CCR2 Antagonists
10/18/2012US20120264761 Aminobenzoquinazolinone M1 Receptor Positive Allosteric Modulators
10/18/2012US20120264760 Compounds and Methods for Treating Mammalian Gastrointestinal Parasitic Infections
10/18/2012US20120264759 Benzyl substituted triazine derivatives and their therapeutical applications
10/18/2012US20120264757 Composition and Method for Treating Hemorrhoids and/or Anorectal Disorders
10/18/2012US20120264756 Phosphatidylcholine Transfer Protein Inhibitors
10/18/2012US20120264755 Pyridinyl derivatives as inhibitors of enzyme nicotinamide phosphoribosyltransferase
10/18/2012US20120264754 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
10/18/2012US20120264753 Novel 1-(biphenyl-4-yl-methyl)-1h-imidazole derivative and pharmaceutical product containing same
10/18/2012US20120264752 Dual-acting antihypertensive agents
10/18/2012US20120264751 Pyrrolopyrazoles, potent kinase inhibitors
10/18/2012US20120264749 Morpholine-spirocyclic piperidine amides as modulators of ion channels
10/18/2012US20120264748 Diaza-spiro[5.5]undecanes
10/18/2012US20120264747 Triazolopyridine jak inhibitor compounds and methods
10/18/2012US20120264746 Cell migration modulating compounds
10/18/2012US20120264745 Methods and compositions for the delivery of a therapeutic agent
10/18/2012US20120264744 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof
10/18/2012US20120264743 Crystalline forms of (r)-8-chloro-1-methyl-2,3,4,5-thtrahydro-1h-3-benzazepine hydrochloride
10/18/2012US20120264742 Pharmaceutical composition for external use
10/18/2012US20120264741 Pharmaceutical compositions and methods for preventing, treating, or reversing neuronal dysfunction
10/18/2012US20120264740 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
10/18/2012US20120264739 Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor
10/18/2012US20120264738 Dispiropyrrolidine derivatives
10/18/2012US20120264737 Heterocyclic Modulators of Lipid Synthesis
10/18/2012US20120264736 Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
10/18/2012US20120264735 Tyrosine kinase inhibitors
10/18/2012US20120264734 Aryl- or Heteroaryl-Substituted Benzene Compounds
10/18/2012US20120264733 Heterocyclic compound and use thereof
10/18/2012US20120264732 Phenyl bicyclic methyl azetidine derivatives as sphingosine-1 phosphate receptors modulators
10/18/2012US20120264731 Chromenone derivatives
10/18/2012US20120264730 Substituted bicyclic methyl azetidines as sphingosine-1 phosphate receptors modulators
10/18/2012US20120264729 Co-crystals and salts of ccr3-inhibitors
10/18/2012US20120264728 Amino-heteroaryl derivatives as hcn blockers
10/18/2012US20120264727 Novel cephalosporin derivatives and pharmaceutical compositions thereof
10/18/2012US20120264726 Methods of sensitizing drug resistant microorganisms using methylsulfonylmethane (msm)
10/18/2012US20120264725 Substituted porphyrins
10/18/2012US20120264724 Antimicrobial agents based on hemin derivatives
10/18/2012US20120264723 Process for the preparation of drospirenone
10/18/2012US20120264722 Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction
10/18/2012US20120264721 Analogues of cilostazol
10/18/2012US20120264720 Identification and treatment of cancer subsets
10/18/2012US20120264719 Dosage regimen of an s1p receptor modulator
10/18/2012US20120264718 Bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
10/18/2012US20120264717 Compounds, Compositions and Methods Comprising Oxadiazole Derivatives
10/18/2012US20120264716 Phenyl bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
10/18/2012US20120264715 Substituted bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
10/18/2012US20120264714 Boron-containing small molecules as anti-inflammatory agents
10/18/2012US20120264713 Use of docosatrienes, resolvins, and their stable analogs in the treatment of airway diseases and asthma
10/18/2012US20120264712 Caries risk test for predicting and assessing the risk of disease
10/18/2012US20120264711 Antiviral compounds
10/18/2012US20120264710 Systems and Methods for Detecting hENT1 Expression in Hematological Disorders
10/18/2012US20120264709 Nucleotide and oligonucleotide prodrugs
10/18/2012US20120264708 Method For Treatment Of Macular Degeneration By Modulating P2Y12 or P2X7 Receptors
10/18/2012US20120264707 Beta-l-2'-deoxy-nucleosides for the treatment of hepatitis b
10/18/2012US20120264706 Purine derivatives as adenosine a1 receptor agonists and methods of use thereof
10/18/2012US20120264705 Antimicrobial compositions comprising 15-hetre and methods of use thereof
10/18/2012US20120264704 Substituted dihydropyrazolones and use thereof as hif-prolyl-4 -hydroxylase inhibitors
10/18/2012US20120264703 Methods And Compositions For The Treatment Of Anxiety Disorders, Including Post Traumatic Stress Disorder (PTSD) And Related Central Nervous System (CNS) Disorders.
10/18/2012US20120264702 Synthesis And Use Of Glycoside Derivatives of Propofol
10/18/2012US20120264701 Use of d-ribose for fatigued subjects
10/18/2012US20120264700 Glycoside derivatives and uses thereof
10/18/2012US20120264698 Method of using dopamine reuptake inhibitors and their analogs for treating autoimmune conditions and delaying or preventing autoimmune related pathologic progressions
10/18/2012US20120264694 Composition comprising torasemide
10/18/2012US20120264692 Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
10/18/2012US20120264681 Buffered ophthalmic compositions and methods of use thereof
10/18/2012US20120264680 Regulation of energy metabolism and obesity by modulating b cell activating factor (baff, blys) or baff signaling
10/18/2012US20120264678 Methods of using [3.2.0] heterocyclic compounds and analogs thereof for treating infectious diseases
10/18/2012US20120264675 Cmv gene products promote cancer stem cell growth
10/18/2012US20120264625 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
10/18/2012US20120263810 Formulations with sanguinarine, chelerythrine or chelidonine for the treatment of warts, verrucas and psoriatic plaques
1 ... 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 ... 7860